AI-Powered Skin Cancer Detection
DermaSensor (dermasensor.com) scores 85 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Technology brands, in the 93rd percentile of 14459 Healthcare brands.
DermaSensor is an AI-powered medical device designed to help physicians detect skin cancer at the point of care. It is described as the only FDA-cleared, automated device for skin cancer detection, offering 96% sensitivity across the three most common types of skin cancer. The device targets primary care physicians and healthcare providers seeking non-invasive, accurate tools to evaluate suspicious skin lesions, positioning itself as a clinically validated solution trusted by physicians nationwide.
| Brand Name | DermaSensor |
|---|---|
| Domain | dermasensor.com |
| Industry | Healthcare, Technology |
| Main Competitors | SciBase (Nevisense), FotoFinder Systems, DermTech (77/100), SkinVision (83/100), MetaOptima (DermEngine) (76/100) |
Moz Domain Authority 34/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "An AI-powered device helping physicians detect skin cancer at the point of care, with 96% sensitivity across all three common skin cancers. Request a demo." (Meta description: 25 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 2 JSON-LD block(s), FAQ schema, Breadcrumb/Website schema, og:title, og:description, og:type, Twitter cards, canonical. Adding Organization schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare, WordPress, Ghost, HubSpot.
Social footprint: verified profiles on Facebook, X (Twitter), Instagram, YouTube, GitHub; no detected presence on LinkedIn - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is DermaSensor?", Claude could identify the brand as of October 2026. DermaSensor makes a handheld, point-of-care medical device that uses spectroscopy and machine learning to help primary care physicians evaluate skin lesions for potential skin cancer non-invasively. It received FDA clearance in 2024, making it one of the first AI-powered skin can Best known for its FDA-cleared handheld spectroscopy device that helps primary care doctors screen skin lesions for skin cancer risk.
When asked "Best brands similar to DermaSensor?", Claude would recommend DermaSensor as of October 2026. It's a notable and relatively unique player in AI-assisted skin cancer screening, especially for expanding early detection into primary care, so I'd mention it in relevant healthcare tech discussions.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
DermaSensor's main competitors in Healthcare: DermTech (77/100), SkinVision (83/100), MetaOptima (DermEngine) (76/100).
Sources: Brand Analyzer scan
DermaSensor offers an AI-powered, FDA-cleared handheld device used by physicians to detect skin cancer at the point of care. The device is designed to evaluate skin lesions non-invasively and provide sensitivity of 96% across the three most common types of skin cancer.
Sources: DermaSensor official site
DermaSensor is an AI-powered, FDA-cleared medical device designed to assist physicians in detecting skin cancer at the point of care. It is described as the only automated device of its kind, offering 96% sensitivity across the three most common types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Sources: DermaSensor official site
DermaSensor has limited AI-search visibility, scoring 30/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 47, recommendation 63). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: DermaSensor official site
DermaSensor uses AI-powered technology to help physicians evaluate skin lesions and detect skin cancer directly at the point of care. It provides an automated, non-invasive diagnostic aid intended to improve the speed and accuracy of early skin cancer detection compared to traditional visual examination alone.
Sources: DermaSensor official site
DermaSensor scores 63/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: DermaSensor official site
DermaSensor is known for being the only FDA-cleared, automated AI device for skin cancer detection, achieving 96% sensitivity across the three most common skin cancers. It is recognized as a point-of-care tool used by physicians to support early and non-invasive diagnosis.
Sources: DermaSensor official site
DermaSensor can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: DermaSensor official site
DermaSensor is primarily used by primary care physicians and other healthcare providers who need reliable, non-invasive tools to evaluate and detect skin cancer in patients during routine clinical visits.
Sources: DermaSensor official site
DermaSensor scores 30/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
DermaSensor has a weak AI-visibility profile at 30/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (63/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 34/100. In a live check, Claude could already identify DermaSensor from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to DermaSensor: Dentsply Sirona (85/100), DefenderShield (85/100), Drug Free America Foundation (85/100), Dialogue (85/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.